Saturday, July 2nd, 2022

Diabetes and insulin, innovative therapies: a gap to be bridged

Given World Diabetes Day (November 14), the open question remains the obstacle course for access to innovative drugs and devices. Non-homogeneous treatment persists between the various regions, which is also why it is necessary to reprogram the diabetic assistance in the light of the inspiring principles of the NRP, with the tools of telemedicine. 

Given World Diabetes Day (November 14), the open question remains the obstacle course for access to innovative drugs and devices. Non-homogeneous treatment persists between the various regions, which is also why it is necessary to reprogram the diabetic assistance in the light of the inspiring principles of the NRP, with the tools of telemedicine.

During a press conference to announce the joint initiatives, diabetologists recommended completing the anti-Covid vaccination cycle. The third booster dose is necessary to avoid new hospitalizations, warn the presidents of the Italian Diabetes Society (SID), Agostino Consoli, and of the Association of Diabetic Doctors (AMD) Graziano Di Cianni.

It has been 100 years since the discovery of insulin, yet there is still a gap to be bridged considering that less than 50% of patients currently receive therapies that meet the indications. Access to treatment, says Consoli, “must be guaranteed to all citizens with diabetes, uniformly throughout the national territory, it is unacceptable that there are twenty or more different health services in Italy, one for each region”. “As a scientific society of Italian diabetology – continues Di Cianni – we must guarantee the equity of access to the best quality of care in terms of innovation and therefore of effectiveness throughout the national territory”.

But what are the technologies that make the difference? We have moved from insulin pumps to sensors that allow you to automatically and continuously monitor glucose levels, to arrive at monitoring systems that allow you to automatically adjust the infusion of the exact amount of insulin to maintain good glycemic control. Insulin pens will also be available shortly to keep the dosage and time of administration in memory.

 

Leave a Reply

Your email address will not be published.